WATSON USES ELEMENTARY FORMULA OF SALES, APPROVALS TO POST CONTINUED GAINS
Executive Summary
Watson Pharmaceutical gained 1-1/16 points in October to continue its steady rise since a month-end low of 15-1/4 in March. The 4.2% gain to 26-5/16 came as the generic drug manufacturer reported positive third quarter results.